As of 2025-01-15, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (75.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -142.3%.
The range of the Relative Valuation is (77.24) - (80.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 27.3x | 17.5x |
| Forward P/E multiples | 18.3x - 19.1x | 18.3x |
| Fair Price | (77.24) - (80.53) | (75.55) |
| Upside | -143.2% - -145.1% | -142.3% |
| Date | P/E |